MLL
Magazine

Here you will find all MLL news as well as scientific contributions to leukemia diagnostics and research

Main article of the month:

The MLL says Thank You

 

Current articles

Prof. Dr. med. Dr. phil. Torsten Haferlach
from 16.12.2020
MLL News
The MLL says Thank You

This very different year is coming to an end. We all had to realize, professionally and privately, that plans and goals are only relative. Furthermore, it became clear how centrally "medicine" can influence our daily lives and actions. We as MLL would like to look back and forward and thank you for the trust you have placed in us and for your cooperation.

PD Dr. med. Gregor Hörmann, PhD
from 16.12.2020
Diagnostics
Molecular genetics in mastocytosis and hypereosinophilia

Advanced molecular genetic testing is gaining ground in the diagnosis of mast cell diseases and hypereosinophilia. In addition to the typical mastocytosis-driver mutation KIT D816 as well as PDGFRA, PDGFRB, FGFR1, and PCM1-JAK2 rearrangements, the MLL uses advanced Next-Generation Sequencing (NGS) mutation analysis to inform the diagnosis and prognostic stratification of these diseases. These NGS gene panels are continuously updated to reflect the latest advances in scientific understanding.

Dr. med. Adriane Koppelle
from 16.12.2020
Diagnostics
Advances in the targeted therapy of hematological neoplasm

In recent years, research into the underlying pathogenetic mechanisms of hematologic neoplasms has led to remarkable advances in our understanding of these diseases. Cytogenetic and molecular aberrations are the most important factors in determining response to chemotherapy and are increasingly also therapeutic targets. We would first like to provide an overview of novel therapies for AML whose target genes can be sequenced in MLL.

Sarah Kurz
from 11.12.2020
MLL News
The MLL Munich Leukemia Laboratory belongs to BAVARIA'S BEST 50

It is now official: As of this year, the MLL Munich Leukemia Laboratory is one of the 50 fastest-growing medium-sized companies in Bavaria. In recent years, the company has been able to increase its sales and the number of its employees at an above-average rate. In recognition of this achievement, MLL was awarded the BAVARIA'S BEST 50 prize by the Bavarian State Ministry of Economic Affairs, Regional Development and Energy (STMWI) and the Deputy Bavarian Prime Minister Hubert Aiwanger.

Newsletter registration


Sign up for our MLL News and receive information on latest findings in leukemia diagnostics and research. Newsletter only available in German.
 
Sign up now